Schroder Investment Management Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,000
| Closed | -$889K | – | 1211 |
|
|
2024
Q4 | $889K | Hold |
23,000
| – | – | ﹤0.01% | 1033 |
|
|
2024
Q3 | $1.09M | Hold |
23,000
| – | – | ﹤0.01% | 1020 |
|
|
2024
Q2 | $1.24M | Hold |
23,000
| – | – | ﹤0.01% | 992 |
|
|
2024
Q1 | $1.57M | Hold |
23,000
| – | – | ﹤0.01% | 958 |
|
|
2023
Q4 | $1.44M | Sell |
23,000
-102,013
| -82% | -$6.39M | ﹤0.01% | 959 |
|
|
2023
Q3 | $5.67M | Sell |
125,013
-1,768
| -1% | -$80.3K | 0.01% | 724 |
|
|
2023
Q2 | $7.12M | Buy |
126,781
+98,770
| +353% | +$5.54M | 0.01% | 710 |
|
|
2023
Q1 | $1.27M | Buy |
+28,011
| New | +$1.27M | ﹤0.01% | 1028 |
|
|
2021
Q4 | – | Sell |
-19,570
| Closed | -$2.19M | – | 1418 |
|
|
2021
Q3 | $2.19M | Buy |
19,570
+7,460
| +62% | +$835K | ﹤0.01% | 962 |
|
|
2021
Q2 | $1.96M | Buy |
+12,110
| New | +$1.96M | ﹤0.01% | 1017 |
|